The Psychedelic Renaissance


Book Description

Praise for Second Edition of The Psychedelic Renaissance: 'Onward, intrepid explorer, keep your wits, while allowing them to be tickled, as Dr Sessa leads you into a world of remarkable wonders! You are in for a real treat!' Robin Carhart-Harris 'This new book is a succinct, entertaining overview of the emerging "Psychedelic Renaissance" written by an insider, and one of the brightest young architects of this new emerging paradigm.' Dr Dennis J. McKenna 'With intelligence, fact-based optimism and compassion Sessa throws open the doors of perception and guides the reader through the complexities of the history, pharmacology, legality and potential of these miraculous molecules.' Andy Roberts 'This new edition of Sessa's, The Psychedelic Renaissance, will encourage researchers to work in this field, to the benefit of our understanding of how the brain works and to develop new approaches to psychiatric disorders.' David Nutt 'Dr. Ben Sessa prescribes a way forward; mainstreaming psychedelics for a world in deep need of spirituality and inspiration. The Psychedelic Renaissance is a book that deserves to be widely read.' Rick Doblin 'Ben Sessa's energetic review of the research and cultural use of psychedelics provides a unique perspective. The way forward is clear: we urgently need more scientific research, and a rational reform of drug policies.' Amanda Feilding 'The Psychedelic Renaissance will inevitably and rightly be seen as an important marker of their assimilation into the cultural mainstream. I highly recommend it.' Ralph Metzner 'Dr. Sessa skilfully chronicles important developments, perhaps a turning point, in psychiatry and in the understanding of psychedelics in the wider culture. This new updated edition of The Psychedelic Renaissance is informative, entertaining and timely.' Michael Mithoefer




Acid Revival


Book Description

A vivid analysis of the history and revival of clinical psychedelic science Psychedelic drugs are making a comeback. In the mid-twentieth century, scientists actively studied the potential of drugs like LSD and psilocybin for treating mental health problems. After a decades-long hiatus, researchers are once again testing how effective these drugs are in relieving symptoms for a wide variety of psychiatric conditions, from depression and obsessive–compulsive disorder to posttraumatic stress disorder and substance addiction. In Acid Revival, Danielle Giffort examines how this new generation of researchers and their allies are working to rehabilitate psychedelic drugs and to usher in a new era of psychedelic medicine. As this team of researchers and mental health professionals revive the field of psychedelic science, they are haunted by the past and by one person in particular: psychedelic evangelist Timothy Leary. Drawing on extensive archival research and interviews with people working on scientific psychedelia, Giffort shows how today’s researchers tell stories about Leary as an “impure” scientist and perform his antithesis to address a series of lingering dilemmas that threaten to rupture their budding legitimacy. Acid Revival presents new information about the so-called psychedelic renaissance and highlights the cultural work involved with the reassembly of dormant areas of medical science. This colorful and accessible history of the rise, fall, and reemergence of psychedelic medicine is infused with intriguing narratives and personalities—a story for popular science aficionados as well as for scholars of the history of science and medicine.




Psychedelic Justice


Book Description

CULTIVATING A PSYCHEDELIC RENAISSANCE THAT INCLUDES EVERYONE Radical, cultural transformation is the guiding force behind this socially visionary anthology. Its unifying value is social justice. It guides us in cultivating a psychedelic renaissance that represents everyone, honors voices that have been suppressed for too long, and envisions a more beautiful tomorrow through a psychedelic lens. Psychedelic culture is at an inflection point. Within the last decade, psychedelics have assimilated into the mainstream, even becoming a multimillion-dollar industry. As they integrate into the dominant culture, a lot of longtime participants in psychedelic communities are wondering: will psychedelics help us revolutionize society, or will they merely reinforce old narratives? As psychedelic medicine integrates into mainstream, capitalist culture, the question of what forces will gain control and shape the direction of the psychedelic renaissance is front and center. In this pivotal time, with so many new players emerging, those of us who believe that psychedelics can help us transform society are being challenged to define, and embody, the values that will shape this growing movement. To do this, we must first acknowledge the shadow side of the psychedelic movement and challenge its longstanding injustices. If the psychedelic renaissance is going to expand and revolutionize society, it must include and serve everybody. The anthology highlights Chacruna's ongoing work promoting diversity and inclusion by prominently featuring voices that have been long marginalized in Western psychedelic culture: women, queer people, people of color, and indigenous people. The essays examine both historical and current issues within psychedelics that many may not know about, and orient around policy, reciprocity, diversity and inclusion, sex and power, colonialism, and indigenous concerns.




The Psychedelic Renaissance


Book Description

Makes the case for the reevaluation of psychedelics and their clinical potential for treating a range of conditions, from post-traumatic stress disorder and depression to autism and cluster headaches.




Essential guide to the Psychedelic Renaissance


Book Description

In this book you will learn all the basics of psychedelics and why all this research is great news for public health in this century. After a very long and strange journey, psychedelics may finally be back for good. Rick Doblin, PhD, Founder & Executive Director, MAPS. In this guide you will learn all the essentials about the history, neuroscience, legality, therapeutic applications and harm reduction of the most promising psychedelic drugs for science. After decades of international prohibition these molecules are returning to laboratories and clinics, hand in hand with the most rigorous science, to revolutionize the way we understand and treat mental health (depression, anxiety, PTSD and addictions). Discover the world of psilocybin, MDMA, DMT, ketamine and LSD, before society immerses in this revolution, which will forever change the perception we have of psychedelics. This guide will be of interest to both therapists and other mental health professionals interested in the clinical applications, parents and educators seeking to understand the impact and safety of psychedelics and other drugs, as well as any adult curious to learn about and explore this new world of the psychedelic renaissance.




When Plants Dream


Book Description

Ayahuasca is a powerful tool for transformation, that more and more Westerners are flocking to drink in a quest for greater self-knowledge, healing and reconnection with the natural world. This formerly esoteric, little-known brew is now a growth industry. But why? Ayahuasca is a psychoactive brew that has a long history of ritual use among indigenous groups of the Upper Amazon. Made from the ayahuasca vine and the leaves of a shrub, it is associated with healing in collective ceremonies and in more intimate contexts, generally under the direction of specialist – an ayahuasquero. These are experienced practitioners who guide the ceremony and the drinkers’ experience. Ayahuasca has gained significant popularity these days in cities around the world. Why? What effect might ayahuasca be having on our culture? Does the brew, which seems to inspire environmental action, simplified lifestyles and more communitarian behaviour, act as an antidote to frenzied consumerist culture? In When Plants Dream, Pinchbeck and Rokhlin explore the economic, social, political, cultural and environmental impact that ayahuasca is having on society. Part 1 covers the background; what ayahuasca is, where it is found, and its cultural origins. Part 2 explores the role and practices of the ayahuasquero in both Amazonian and Western cultures. Part 3 examines the medicinal plants of the Amazon, looking particularly at the ingredients in ayahuasca and their therapeutic qualities, covering the most up-to-date biomedical research, psychedelic science and psychopharmacology. It also covers all the legal aspects of ayahuasca use. Lastly in Part 4 Pinchbeck and Rokhlin question the future of ayahuasca. When Plants Dream is the first book of its kind to look at the science and expanding culture of ayahuasca, from its historical use to its appropriation by the West and the impact it is having on cultures beyond the Amazon.




Psychedelic Healing


Book Description

Psychedelics as therapeutic catalysts for emotional and spiritual transformation • Explores the latest medical research on the healing powers of entheogens • Reveals the crucial role of tribal and shamanic wisdom in psychedelic medicine • Provides guidelines for working with psychedelics, including the author’s personal healing and recommendations for creating change on the spiritual and societal levels Banned after promising research in the 1940s, ’50s, and ’60s, the use of psychedelics as therapeutic catalysts is now being rediscovered at prestigious medical schools, such as Harvard, Johns Hopkins, NYU, and UCLA. Through clinical trials to assess their use, entheogens have been found to ease anxiety in the dying, interrupt the hold of addictive drugs, cure post-traumatic stress disorder, and treat other deep-seated emotional disturbances. To date, results have been positive, and the idea of psychedelics as powerful psychiatric--and spiritual--medicines is now beginning to be accepted by the medical community. Exploring the latest cutting-edge research on psychedelics, along with their use in indigenous cultures throughout history for rites of passage and shamanic rituals, Neal Goldsmith reveals that the curative effect of entheogens comes not from a chemical effect on the body but rather by triggering a peak or spiritual experience. He provides guidelines for working with entheogens, groundbreaking analyses of the concept--and the process--of change in psychotherapy, and, ultimately, his own story of psychedelic healing. Examining the tribal roots of this knowledge, Goldsmith shows that by combining ancient wisdom and modern research, we can unlock the emotional, mental, and spiritual healing powers of these unique and powerful tools, providing an integral medicine for postmodern society.




The Trials of Psychedelic Therapy


Book Description

The rise—and fall—of research into the therapeutic potential of LSD. After LSD arrived in the United States in 1949, the drug's therapeutic promise quickly captured the interests of psychiatrists. In the decade that followed, modern psychopharmacology was born and research into the drug's perceptual and psychological effects boomed. By the early 1960s, psychiatrists focused on a particularly promising treatment known as psychedelic therapy: a single, carefully guided, high-dose LSD session coupled with brief but intensive psychotherapy. Researchers reported an astounding 50 percent success rate in treating chronic alcoholism, as well as substantial improvement in patients suffering from a range of other disorders. Yet despite this success, LSD officially remained an experimental drug only. Research into its effects, psychological and otherwise, dwindled before coming to a close in the 1970s. In The Trials of Psychedelic Therapy, Matthew Oram traces the early promise and eventual demise of LSD psychotherapy in the United States. While the common perception is that LSD's prohibition terminated legitimate research, Oram draws on files from the Food and Drug Administration and the personal papers of LSD researchers to reveal that the most significant issue was not the drug's illegality, but the persistent question of its efficacy. The landmark Kefauver-Harris Drug Amendments of 1962 installed strict standards for efficacy evaluation, which LSD researchers struggled to meet due to the unorthodox nature of their treatment. Exploring the complex interactions between clinical science, regulation, and therapeutics in American medicine, The Trials of Psychedelic Therapy explains how an age of empirical research and limited government oversight gave way to sophisticated controlled clinical trials and complex federal regulations. Analyzing the debates around how to understand and evaluate treatment efficacy, this book will appeal to anyone with an interest in LSD and psychedelics, as well as mental health professionals, regulators, and scholars of the history of psychiatry, psychotherapy, drug regulation, and pharmaceutical research and development.




Trip


Book Description

Part memoir, part history, part journalistic exposé, Trip is a look at psychedelic drugs, literature, and alienation from one of the twenty-first century's most innovative novelists--The Electric Kool-Aid Acid Test for a new generation. A Vintage Original. While reeling from one of the most creative--but at times self-destructive--outpourings of his life, Tao Lin discovered the strange and exciting work of Terence McKenna. McKenna, the leading advocate of psychedelic drugs since Timothy Leary, became for Lin both an obsession and a revitalizing force. In Trip, Lin's first book-length work of nonfiction, he charts his recovery from pharmaceutical drugs, his surprising and positive change in worldview, and his four-year engagement with some of the hardest questions: Why do we make art? Is the world made of language? What happens when we die? And is the imagination more real than the universe? In exploring these ideas and detailing his experiences with psilocybin, DMT, salvia, and cannabis, Lin takes readers on a trip through nature, his own past, psychedelic culture, and the unknown.




Psychedelic Medicine


Book Description

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers non-technical summaries of the most recent, double-blind, placebo-controlled studies with MDMA, psilocybin, LSD, and ayahuasca • Includes the work of Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.